New Advertising Guidelines

Australia has the world’s strictest regulations around advertising in the cosmetic industry. This severely limits the terms that businesses can use when communicating their offerings to patients.

Brand names such as “Botox” have been banned by the Therapeutic Goods Administration for years. But as of an upcoming regulatory guidance change beginning early 2024, previously TGA approved terms such as “dermal filler” and “anti-wrinkle injections” will now also be banned.

While the TGA’s aim appears to be to protect consumers, the feedback that we’ve had from patients is that it is extremely confusing, leading in some cases to more risk for consumers who may not be able to easily find the treatments they seek.

Regardless, Dermaq Aesthetics must of course comply with all Australian regulations, including this new guidance from the TGA. As such we will be removing terms such as “dermal filler” and “anti-wrinkle injections” from all of our advertising materials, as we seek to come up with suitable ways to convey our offerings to potential clients.

We deeply regret any confusion this is likely to cause as we seek to maintain compliance with the rapidly shifting regulatory landscape. While the TGA claims that this is intended to ensure the consistent application of legislation across all areas of the cosmetic industry, it has been noted that terms such as “breast enhancement” are not restricted. The TGA is overseen by the Department of Health, so if you do feel this is unreasonable, the best place to contact would be your local MP. In the mean time, if you have any questions or concerns you are more than welcome to contact us or come and visit us in clinic, and we will do our best to assist you.

We appreciate your patience whilst we try to navigate these difficult waters.